Dear Colleagues,                                                                                                     

It is with great pleasure that the Histiocyte Society welcomes you to Stockholm for its 38th Annual Meeting, to be held September 18-20, 2022.  This year we are finally returning to an in-person meeting format!  After pivoting to virtual-only formats in 2020 and 2021, this will be our first in-person meeting since 2019.  Of course, as technology now makes it possible, for those who cannot be there in person, we will also offer a virtual attendance option.  But since we would all prefer to see each other face to face, I hope to see all of you in Stockholm this fall. 

This year’s program continues to offer the cutting edge of clinical and scientific advances related to the histiocytoses.  Our program will feature symposia focused on HLH and LCH.  The HLH symposium, titled “Expanding/ refining our understanding of harmful immune activation” will examine HLH in contexts beyond familial HLH.  The LCH symposium, “New Horizons for LCH”, will focus on MAPK inhibition and the questions surrounding upfront and/or longer-term use.  Since we last met in Stockholm in 2004, our field has advanced tremendously with new insights into disease pathogenesis and new, effective targeted therapies for all forms of histiocytoses. In 2004, we were honored to have Her Majesty Queen Silvia of Sweden join a portion of our meeting. This year, we are looking forward to another visit from Her Majesty.  Fittingly, during the queen’s visit, we will host a special symposium focused on updates in HLH and LCH over the past two decades.  Finally, YOU will be key ingredient for an exciting meeting.  Not only your cutting-edge science, displayed in short talks and a poster session, but your presence after a long world-wide struggle with an unfortunate pandemic, will make our meeting a vigorous, joyous, and memorable one.

A highlight of the meeting each year is the Annual Banquet. This year’s banquet will be no exception as it will be held at the lovely Operakällaren, so named for its prior location under Gustav III’s opera house.   Our meeting will be held at the Grand Hotel in downtown Stockholm, with pre-meeting sessions at the Karolinska Institute. Our welcome reception will be hosted at historic Stockholm city hall.  Finally, on Monday night (after the poster session) there will be optional excursions available for an additional cost to either the ABBA Museum or a dinner boat cruise around Stockholm. 

As you know, a great deal of time, energy and resources go into planning the meeting each year. We are grateful to our long-term partner and sponsor, the Histiocytosis Association, as well as our other sponsors, without whose generous support this meeting would not be possible.  Finally, we are all grateful to our local host, Jan-Inge Henter, for his tireless efforts to make this an excellent meeting.

Looking forward to seeing you all in Stockholm!.  

Michael Jordan
President
Histiocyte Society